Prefronto–cerebellar transcranial direct current stimulation improves visuospatial memory, executive functions, and neurological soft signs in patients with euthymic bipolar disorder by Minichino, Amedeo et al.
© 2015 Minichino et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0)  
License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further 
permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on 
how to request permission may be found at: http://www.dovepress.com/permissions.php
Neuropsychiatric Disease and Treatment 2015:11 2265–2270
Neuropsychiatric Disease and Treatment Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
2265
O r i g i N a l  r e s e a r c h
open access to scientific and medical research
Open access Full Text article
http://dx.doi.org/10.2147/NDT.S79108
Prefronto–cerebellar transcranial direct current 
stimulation improves visuospatial memory, 
executive functions, and neurological soft signs 
in patients with euthymic bipolar disorder
amedeo Minichino
Francesco saverio Bersani
laura Bernabei
Francesco spagnoli
lucilla Vergnani
alessandra corrado
ines Taddei
Massimo Biondi
roberto Delle chiaie
Department of Neurology and 
Psychiatry, sapienza University 
of rome, rome, italy
Objective: The aim of the study was to improve neuropsychological functioning of euthymic 
patients with bipolar disorder (BD) using transcranial direct current stimulation (tDCS) applied 
to cerebellar and prefrontal cortices.
Methods: Twenty-five BD outpatients underwent prefrontal (anodal) and cerebellar (cathodal) 
tDCS for 3 consecutive weeks. All participants were assessed through the Rey Complex Figure 
Test delay and copy and the Neurological Examination Scale at baseline and after therapy with 
tDCS.
Results: After tDCS treatment, patients showed significant improvements in visuospatial 
memory tasks. Patients with worse baseline cognitive performances also showed a significant 
improvement in executive functioning tasks. Neurological Examination Scale total score and 
motor coordination subscale significantly improved.
Conclusion: Prefrontal-excitatory and cerebellar-inhibitory stimulations in euthymic BD 
patients may lead to better neurocognitive performances. This improvement could result from 
the modulation of prefronto–thalamic–cerebellar circuit activity pattern, which can be disrupted 
in BD.
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Introduction
Bipolar disorder (BD) is a severe and disabling disease. The course of BD has 
traditionally been viewed as episodic, ie, with symptomatic, functional, and cognitive 
recovery between mood episodes.1,2 However, clinical evidence recently showed that 
many BD individuals experience difficulties in daily functioning (eg, higher rates of 
unemployment and disability than healthy controls)3–5 as well as neuropsychological 
and social deficits even during the euthymic phase of the disease, despite symptomatic 
mood improvements.
Consistently, an increasing number of clinical observations have been considering 
the cognitive and social impairments observed in BD as trait-associated, rather than 
state-associated, characteristics of the disorder.6–10 In particular, visuospatial memory 
and executive functions have been found to be the neuropsychological domains that 
are more significantly impaired in euthymic BD patients in comparison with healthy 
controls.8–10
The neurological soft signs (NSS) are minor neurological abnormalities in sen-
sory and motor performances well established in schizophrenia.11,12 They have been 
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described in patients with BD13,14 not only during the mood 
dysregulation episodes, but also in the euthymic phase of 
the disease.15 In addition, various research has observed 
deficits in NSS expression and deficits in executive func-
tions, suggesting that the disturbances in the two areas of 
brain functioning domains may result from the alteration of 
similar underlying neurobiological substrates.15,16
Recent studies hypothesize that cognitive impairments 
in BD patients could be related to prefronto–thalamic–
cerebellar circuit dysfunction and, in particular, to the loss 
of the physiological inverse metabolic activity between 
the dorsolateral prefrontal cortex (DLPFC) and subcortical 
areas.17–21 In particular, some studies suggest that hypoac-
tivation of the left DLPFC observed in BD could lead to 
hyperactivation of subcortical structures such as the right 
cerebellar hemisphere.17,18,20 A disruption of prefronto–
cerebellar circuitry in severe mental disorders was first 
suggested by Andreasen et al who specifically coined the 
term of “cognitive dysmetria”.22
Transcranial direct current stimulation (tDCS) is a brain-
modulating technique using constant, low current delivered 
directly to the brain areas of interest via inhibitory (cathodal) 
and excitatory (anodal) electrodes.23–25 Intracerebral cur-
rent flow between the two electrodes excites neurons in the 
regions of interest, producing both neurophysiological and 
behavioral changes in the participant.23–25 Considering the 
modulatory properties of tDCS, it is possible to hypothesize 
that concomitant excitatory stimulation of left DLPFC and 
inhibitory stimulation of right cerebellar hemisphere might 
modulate prefronto–cerebellar circuitry, potentially resulting 
in neurological and neuropsychological improvements.
Previous studies showed that anodal stimulation of 
DLPFC can improve cognitive performances in both patients 
and healthy individuals,26 while one study showed that cath-
odal stimulation of cerebellum increased cognitive perfor-
mances in healthy people.27 To the best of our knowledge, 
anodal stimulation of DLPFC and cathodal stimulation of 
cerebellum have never been applied: 1) concomitantly and 
2) in a sample of euthymic bipolar patients.
In the present study we used tDCS on both the right cer-
ebellum hemisphere (cathodal, ie, inhibitory modulation) and 
left DLPFC (anodal, ie, excitatory modulation) to investigate 
the effects on visuospatial memory, executive functioning, 
and NSS performances in euthymic BD patients.
Methods
Participants and study design
Twenty-seven outpatients with a diagnosis of BD type I or II 
referring at the Policlinico Umberto I University Hospital, 
Sapienza University of Rome, have been enrolled in the study. 
Patients were in the euthymic phase of the disorder (this was 
as assessed by Hamilton Depression Rating Scale score ,7 
and Young Mania Rating Scale ,7).28,29 Some of these par-
ticipants had previously been enrolled by our research team 
in other studies with different aims and objectives.19,30
Exclusion criteria were: concomitant neurological 
diseases, other axis I diagnosis, hospitalization in the last 
12 months, left handedness, pharmacological treatment 
with typical antipsychotics, Hamilton Depression Rating 
Scale score .7, Young Mania Rating Scale .7, and mental 
retardation (IQ ,70).
tDCS was administered as an add-on treatment to patients 
who had been stable on a standard course of pharmacological 
maintenance therapies for at least 2 months. All participants were 
assessed at baseline and the day after the last tDCS session.
All participants signed written informed consent. The 
research protocol was approved by the Ethical Committee 
of Human Experimentation of Policlinico Umberto I Uni-
versity Hospital and was in accordance with the Helsinki 
Declaration of 1975.
tDcs
tDCS was applied through two sponge electrodes (surface 
area =25 cm2) moistened with a saline solution. The electrode 
montage was: cathodal tDCS on the right cerebellar cortex, 
1 cm under, and 4 cm lateral to the inion (approximately 
comparable to the projection of cerebellar lobule VII onto the 
scalp); anodal tDCS over the left DLPFC (electrode position 
was determined by the International 10/20 System for EEG 
Electrodes, such as that Fp1 corresponded to the DLPFC). The 
onset and offset of the intervention involved current being 
increased and decreased, respectively, in a ramp-like manner 
over 10 seconds. The intensity of stimulation was set at 2 mA 
and delivered for 20 minutes every working day (Monday to 
Friday) for 3 consecutive weeks using a Magstim DC Stimu-
lator Plus and was considered a safe level of exposure, well 
below the threshold for causing tissue damage.27,31
Neuropsychological and neurological 
assessment
To test visuospatial memory, participants completed the 
Rey Complex Figure Test (RCFT) after short and long 
(immediately and 20 minutes, respectively) delays, while the 
RCFT copy was used to measure executive functioning.32 To 
minimize the “learning effect”, parallel (ie, different) versions 
of RCFT were used in pre- and post-treatment evaluations.
The neurological examination was performed through 
the Neurological Evaluation Scale (NES),33 which includes 
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26 items listing the more frequent and significant NSS. 
Trained evaluators administered the scales based on the 
original scoring instructions, and items were scored as 0 
(no abnormality), 1 (mild but definite impairment), and 
2 (marked impairment). Two items (the suck and snout 
reflex) were scored 0 (absent) or 2 (present). The results 
show the total score and the three main subscale scores 
(sensorial integration, motor coordination, and motor 
sequencing).
statistical analysis
The data were analyzed through SPSS software version 20. 
Data were normally distributed and a paired sample t-test 
was used to compare pre- and post-treatment measures. The 
significance threshold was P,0.05.
Results
Two patients did not complete the stimulation protocol 
because of the onset of migraine. The remaining 25 
patients tolerated tDCS without complications with the 
exception of three patients complaining of a transient 
burning sensation surrounding the electrode site. Demo-
graphic and clinical characteristics of these patients are 
given in Table 1.
Visuospatial memory (measured through the RCFT 
delay test) improved significantly (P,0.01) after the treat-
ment, although no significant changes were observed in the 
executive functions domain (measured through the RCFT 
copy test) (Table 2). NES total score and motor coordina-
tion subscale showed significant improvements after tDCS 
treatment (P,0.01) (Table 2; Figure 1).
To evaluate if the degree of the baseline cogni-
tive impairment in BD patients could influence the 
neuropsychological outcomes of the tDCS treatment, we 
performed supplementary analyses dividing the whole 
sample into two subgroups of patients: 1) high baseline 
performances (HBP) group comprised patients with an 
average baseline score above the median value of the 
neuropsychological domain of interest; 2) low baseline 
performances (LBP) group comprised patients with an 
average baseline score below the median value of the neu-
ropsychological domain of interest. LBP patients showed 
a more relevant improvement than HBP patients in both 
visuospatial (RCFT delay test) and executive functions 
(RCFT copy test) domains (Table 2).
Table 1 clinical and sociodemographic data
Patients (n) 25
age, years (mean ± standard deviation) 41.9±12.62
sex
Males (n)
Females (n)
8
17
civil status
Married (n)
single (n)
Others (divorced + widowed) (n)
8
11
6
Number of years in school
#9 (n)
.9 (n)
6
19
Diagnosis
Bipolar disorder i (n)
Bipolar disorder ii (n)
15
10
Disease duration, years (mean ± standard deviation) 17.08±12.05
age at onset of illness, years (mean ± standard deviation) 28.79±12.60
Psychiatric medication
lithium (n)
anticonvulsants (n)
atypical (n)
Benzodiazepines (n)
antidepressants (n)
12
17
17
10
5
Table 2 Mean scores of neuropsychological and Nes assessments pre-tDcs and post-tDcs
Pre-tDCS evaluation Post-tDCS evaluation P-value
Neuropsychological evaluation
rcFT copy 26.29±5.76 28.00±7.66 0.41
lBP patients 21.95±4.50 27.19±4.58 0.01*
hBP patients 31.00±1.99 28.91±10.41 0.50
rcFT delay 8.42±6.22 13.71±6.51 0.01*
lBP patients 3.37±3.41 9.04±4.26 ,0.01*
hBP patients 13.37±4.26 17.74±5.67 0.06
NES
Motor coordination 1.91±1.54 0.39±0.65 ,0.01*
Motor sequencing 3.77±2.84 2.22±2.61 0.06
sensory integration 2.00±1.48 1.43±1.85 0.26
Total score 11.77±6.48 5.91±4.44 ,0.01*
Note: *P,0.05. Data are presented as mean ± standard deviation.
Abbreviations: hBP, high baseline performances; lBP, low baseline performances; Nes, Neurological evaluation scale; rcFT, rey complex Figure Test; tDcs, transcranial 
direct current stimulation.
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Discussion
To the best of our knowledge, this is the first study investi-
gating the effect of prefronto–cerebellar tDCS on cognitive 
performances in euthymic BD patients.
Cognitive deficits have gained considerable importance as 
critical features of a wide range of psychiatric disorders10,34–38 
and they post an important therapeutic challenge.7,8,39 While 
there is overwhelming evidence on the efficacy of psycho-
tropic medications in the management of clinical symptoms, 
cognitive gains are often poor.7,8,39 Thus, it is currently 
accepted that cognitive impairment and symptomatic mani-
festations of mental disorders require separate and integrated 
therapeutic approaches.
The results of the present research preliminarily 
suggest that concomitant prefrontal-excitatory and 
cerebellar-inhibitory tDCS might have a positive effect 
on visuospatial memory and executive functioning in 
euthymic BD patients. Andreasen’s idea of “cognitive 
dysmetria” hypothesized that a general loss of mental 
processes coordination could be the consequence of 
prefronto–thalamic–cerebellar circuit disruption,22 and 
this idea has been supported by several subsequent 
studies.17,18,20 It is thus speculatively possible that the 
cognitive improvements observed in our patients may be 
at least partially attributable to a functional modulation of 
prefronto-cerebellar circuitry activity.
Stratifying the patients according to baseline cognitive 
functions, we found that LBP patients showed significantly 
improved executive functions and presented more significant 
benefits in visuospatial memory than HBP patients. This 
finding suggests that individuals with more severe cognitive 
impairments, that are often the most clinically severe and the 
most difficult to treat, may obtain more substantial benefits 
from prefronto–cerebellar tDCS.
NSS are indicators of neurological impairment fre-
quently observed in schizophrenia and in other psychiatric 
disorders;11–15 our results showed that prefronto-cerebellar 
tDCS led to significant improvements of the NES total score 
and NES motor coordination subscale.
A recent diffusion tensor imaging study found an inverse 
correlation between NSS severity and the integrity of thal-
amic–cerebellar tracts,40 supporting our study hypothesis. 
Furthermore, Goswami et al recently found a correlation 
between NSS and executive dysfunctions in euthymic BD 
patients, potentially involving an inadequate functioning 
of prefrontal cortex;15 this evidence is consistent with our 
results, as both NSS and executive functions improved after 
DLPFC stimulation.
Conclusion
In conclusion, the present study provides preliminary evi-
dence that concomitant prefrontal-excitatory and cerebellar-
inhibitory tDCS in euthymic BD patients may lead to better 
neurocognitive performances, quantified through neuropsy-
chological and neurological measures. We suggest that this 
improvement is at least partially attributable to functional 
modulations of prefronto-cerebellar circuitry activity, which 
has been proven to be altered in BD as well as in other psychi-
atric disorders. Prefronto–cerebellar tDCS could potentially 
represent an inexpensive, easy to administer, non-invasive, 
and painless therapy to increase the effectiveness of standard 
BD treatment.
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Figure 1 Mean scores and standard deviations of neuropsychological and Nes assessments pre- and post-tDcs.
Note: *P,0.05.
Abbreviations: Nes, Neurological evaluation scale; rcFT, rey complex Figure Test; tDcs, transcranial direct current stimulation.
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The small sample size and the absence of a sham control 
group are major limitations of the study. In addition, we 
assessed a relatively large number of measures and we did 
not correct for multiple comparisons; therefore, these results 
are exploratory/hypothesis-generating and further studies 
are needed.
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